文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

糖皮质激素治疗成人重症脓毒性休克的有效性与安全性:随机对照试验的Meta分析

The Effectiveness and Safety of Corticosteroids Therapy in Adult Critical Ill Patients With Septic Shock: A Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · Shock · 2019-01-01
一句话结论在成人重症脓毒性休克中,糖皮质激素未显著降低28天死亡率,但可能与ICU住院时间缩短相关(WMD −1.55天,95%CI −2.19至−0.91)。

该Meta分析系统检索PUBMED、EMBASE、Web of Science和Cochrane Library数据库(建库至2018年3月24日),纳入18项随机对照试验、共8128例成人重症脓毒性休克患者,评估糖皮质激素治疗的有效性与安全性。主要终点28天死亡率在糖皮质激素组与安慰剂组间无显著差异(RR=0.94,95%CI 0.84-1.05,P=0.285)。糖皮质激素组ICU住院时间显著缩短(WMD=−1.55,95%CI −2.19至−0.91,P=0.000)。90天死亡率、ICU死亡率、院内死亡率、总住院时间、休克逆转及重叠感染在两组间均无显著差异(P>0.05),按高剂量或低剂量分层的亚组结果相似。

要点

  • 成人重症脓毒性休克中,糖皮质激素未显著降低28天死亡率(RR=0.94,95%CI 0.84-1.05,P=0.285)。
  • 糖皮质激素组ICU住院时间显著短于安慰剂组(WMD=−1.55天,95%CI −2.19至−0.91,P=0.000)。
  • 90天死亡率、ICU死亡率、院内死亡率、总住院时间、休克逆转及重叠感染两组间无显著差异(P>0.05)。
  • 按高剂量或低剂量糖皮质激素分层的亚组分析结果与总体相似。
  • 该Meta分析纳入18项随机对照试验、8128例成人重症脓毒性休克患者。

适用人群与场景

  • 成人重症脓毒性休克患者,纳入18项随机对照试验共8128例。

研究设计与关键结果

  • 研究类型为Meta分析,纳入18项随机对照试验、8128例成人重症脓毒性休克患者,检索PUBMED、EMBASE、Web of Science、Cochrane Library数据库至2018年3月24日。
  • 主要终点28天死亡率:糖皮质激素组与安慰剂组无显著差异(RR=0.94,95%CI 0.84-1.05,Z=1.07,P=0.285)。
  • ICU住院时间:糖皮质激素组较安慰剂组显著缩短(WMD=−1.55,95%CI −2.19至−0.91,Z=4.74,P=0.000)。
  • 90天死亡率、ICU死亡率、院内死亡率、总住院时间、休克逆转及重叠感染在糖皮质激素组与安慰剂组间均无显著差异(P>0.05)。
  • 按糖皮质激素高剂量或低剂量分层的亚组分析结果相似。

证据类型、等级与局限

  • 证据类型为随机对照试验的Meta分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该Meta分析提示,对成人重症脓毒性休克患者使用糖皮质激素可能与ICU住院时间缩短相关,但28天死亡率与安慰剂相似。
  • 原文未根据结果给出糖皮质激素的剂量、给药途径或疗程推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the effectiveness and safety of corticosteroids therapy in adult critical ill patients with septic shock.

METHODS: The PUBMED, EMBASE, Web of Science, Cochrane Library databases were systematically searched from the inception dates to March 24, 2018. To identify randomized controlled trials that evaluating the role of corticosteroids therapy in adult critical ill patients with septic shock. The primary outcome was 28-day mortality. The second outcomes included 90-day mortality, intensive care unit (ICU) mortality, in-hospital mortality, length of stay in ICU, length of stay in hospital, reversal of shock, and superinfection.

RESULTS: A total of 18 randomized controlled trials involving 8,128 adult critical ill patients with septic shock fulfilled the inclusion criteria. The outcomes of this meta-analysis showed that corticosteroids therapy did not significantly reduce the 28-day mortality [RR = 0.94; 95% CI, 0.84-1.05; Z = 1.07 (P = 0.285)]. However, corticosteroids therapy was associated with a significantly shorter length of stay in ICU [WMD = -1.55; 95% CI, -2.19 to -0.91; Z = 4.74 (P = 0.000)]. 90-day mortality, ICU mortality, in-hospital mortality, length of stay in hospital, reversal of shock, and superinfection had no significant difference between the corticosteroids therapy and placebo therapy (P > 0.05). Similar results were obtained in subgroups of trials stratified according to the dose of corticosteroids (high dose or low does).

CONCLUSIONS: Based on the results of this meta-analysis, corticosteroids therapy was associated with a significantly shorter length of stay in ICU among adult critical ill patients with septic shock. The mortality was similar between the corticosteroids therapy and placebo.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wen Y, Zhu Y, Jiang Q, et al. The Effectiveness and Safety of Corticosteroids Therapy in Adult Critical Ill Patients With Septic Shock: A Meta-Analysis of Randomized Controlled Trials. Shock. 2019. PMID: 29889815. doi:10.1097/SHK.0000000000001202

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。